Next Article in Journal
Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?
Next Article in Special Issue
Involvement of PI3K Pathway in Glioma Cell Resistance to Temozolomide Treatment
Previous Article in Journal
Biology of the mRNA Splicing Machinery and Its Dysregulation in Cancer Providing Therapeutic Opportunities
Previous Article in Special Issue
Dual Specificity Kinase DYRK3 Promotes Aggressiveness of Glioblastoma by Altering Mitochondrial Morphology and Function
 
 
Review

Article Versions Notes

Int. J. Mol. Sci. 2021, 22(10), 5111; https://doi.org/10.3390/ijms22105111
Action Date Notes Link
article pdf uploaded. 12 May 2021 12:07 CEST Version of Record https://www.mdpi.com/1422-0067/22/10/5111/pdf-vor
article xml file uploaded 13 May 2021 08:47 CEST Original file -
article xml uploaded. 13 May 2021 08:47 CEST Update -
article pdf uploaded. 13 May 2021 08:47 CEST Updated version of record https://www.mdpi.com/1422-0067/22/10/5111/pdf-vor
article html file updated 13 May 2021 08:48 CEST Original file -
article html file updated 13 May 2021 10:04 CEST Update -
article xml file uploaded 17 May 2021 13:32 CEST Update -
article xml uploaded. 17 May 2021 13:32 CEST Update -
article pdf uploaded. 17 May 2021 13:32 CEST Updated version of record https://www.mdpi.com/1422-0067/22/10/5111/pdf-vor
article html file updated 17 May 2021 13:33 CEST Update -
article xml file uploaded 17 May 2021 13:35 CEST Update -
article xml uploaded. 17 May 2021 13:35 CEST Update https://www.mdpi.com/1422-0067/22/10/5111/xml
article pdf uploaded. 17 May 2021 13:35 CEST Updated version of record https://www.mdpi.com/1422-0067/22/10/5111/pdf
article html file updated 17 May 2021 13:36 CEST Update -
article html file updated 26 July 2022 19:05 CEST Update https://www.mdpi.com/1422-0067/22/10/5111/html
Back to TopTop